Cuenta de resultados
WEST PHARMACEUTICAL SERVICES INC
WST
Resumen del rendimiento
Haga clic en cualquier fila de la tabla para añadirla al gráfico
en millones de USD
| Métrica | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2010 2010 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ingresos
|
3,074.10 | 2,893.20 | 2,949.80 | 2,886.90 | 2,831.60 | 2,146.90 | 1,839.90 | 1,720.90 | 1,599.10 | 1,509.10 | 1,399.80 | 1,421.40 | 1,368.40 | 1,266.40 | 1,104.70 |
|
Coste de los ingresos
|
1,970.10 | 1,894.70 | 1,820.60 | 1,750.70 | 1,655.80 | 1,379.10 | 1,234.20 | 1,172.00 | 1,086.50 | 1,008.00 | 944.00 | 973.60 | 933.70 | 878.70 | 786.60 |
|
Beneficio bruto
|
1,104.00 | 998.50 | 1,129.20 | 1,136.20 | 1,175.80 | 767.80 | 605.70 | 545.40 | 512.60 | 501.10 | 455.80 | 447.80 | 434.70 | 387.70 | 318.10 |
|
Gastos operativos
|
467.90 | 407.60 | 421.80 | 375.40 | 415.60 | 348.90 | 311.60 | 303.20 | 281.70 | 276.60 | 267.10 | 266.00 | 272.80 | 251.30 | 211.60 |
|
Investigación y desarrollo
|
74.30 | 69.10 | 68.40 | 58.50 | 52.80 | 46.90 | 38.90 | 40.30 | 39.10 | 36.80 | 34.10 | 37.30 | 37.90 | 33.20 | 23.90 |
|
Ventas, generales y administrativos
|
393.60 | 338.50 | 353.40 | 316.90 | 362.80 | 302.00 | 272.70 | 262.90 | 242.60 | 239.80 | 233.00 | 228.70 | 234.90 | 218.10 | 187.70 |
|
Otros gastos operativos
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Resultado de explotación
|
636.10 | 590.90 | 707.40 | 760.80 | 760.20 | 418.90 | 294.10 | 242.20 | 230.90 | 224.50 | 188.70 | 181.80 | 161.90 | 136.40 | 106.50 |
|
Ingresos no operativos
|
35.20 | 5.40 | 22.00 | -54.10 | -3.40 | -5.60 | 2.30 | -24.20 | -11.30 | -17.40 | -47.00 | -41.20 | -55.10 | -51.10 | 32.00 |
|
Ingresos por intereses
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Gastos por intereses
|
15.10 | 16.20 | 14.80 | 11.60 | 10.20 | 9.60 | 9.40 | 9.30 | 10.50 | 11.70 | 15.60 | 18.10 | 18.60 | 18.60 | 16.80 |
|
Otros ingresos/gastos no operativos
|
-1.00 | -1.00 | 3.00 | -51.30 | 3.80 | 1.20 | 0.00 | 6.70 | 9.20 | 8.20 | 5.80 | 5.30 | 5.40 | 4.80 | 4.40 |
|
Resultado antes de impuestos
|
600.90 | 585.50 | 698.00 | 679.90 | 748.90 | 401.30 | 313.60 | 266.40 | 242.20 | 241.90 | 235.70 | 223.00 | 217.00 | 187.50 | 74.50 |
|
Gasto por impuesto sobre beneficios
|
107.20 | 92.80 | 104.60 | 94.00 | 87.10 | 55.10 | 59.00 | -1.20 | -33.10 | -1.80 | -19.80 | -1.20 | -3.20 | 32.70 | 9.20 |
|
Participaciones no dominantes
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00 |
|
Beneficio neto
|
493.70 | 492.70 | 593.40 | 585.90 | 661.80 | 346.20 | 241.70 | 209.90 | 150.70 | 143.60 | 95.60 | 127.10 | 112.30 | 80.70 | 65.30 |
Información complementaria
Datos por acción, partidas derivadas y otras – no forman parte de la cuenta de resultados
en millones de USD, salvo que se indique lo contrario
| Métrica | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2010 2010 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciación y amortización
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
636.10 | 590.90 | 707.40 | 760.80 | 760.20 | 418.90 | 294.10 | 242.20 | 230.90 | 224.50 | 188.70 | 181.80 | 161.90 | 136.40 | 106.50 |
|
Beneficio por acción (básico)
|
6.83 | 6.75 | 7.98 | 7.87 | 8.89 | 4.68 | 3.27 | 2.80 | 2.04 | 1.96 | 1.33 | 1.79 | 1.61 | 2.37 | 1.96 |
|
BPA diluido
|
6.79 | 6.69 | 7.88 | 7.73 | 8.67 | 4.57 | 3.21 | 2.74 | 1.99 | 1.91 | 1.30 | 1.75 | 1.57 | 2.30 | 1.89 |
|
Promedio ponderado de acciones
|
72.30 | 73.00 | 74.30 | 74.40 | 74.40 | 73.90 | 74.00 | 73.90 | 73.90 | 73.30 | 72.00 | 70.90 | 69.60 | 34.00 | 33.30 |
|
Promedio ponderado diluido de acciones
|
72.70 | 73.70 | 75.30 | 75.80 | 76.30 | 75.80 | 75.40 | 75.40 | 75.80 | 75.00 | 73.80 | 72.80 | 71.40 | 35.90 | 36.70 |
|
Resultado global
|
646.30 | 378.40 | 632.60 | 562.50 | 612.80 | 385.20 | - | - | - | - | - | - | - | - | 53.70 |